Ethical acceptability of human challenge trials: Consultation with the US public and with research personnel
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0307808 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von James William Benjamin Elsey und 4 weiteren Autor:innen. Beteiligte Einrichtung: Rethink Priorities, San Francisco, California, United States of America. Hauptthemen laut MEDLINE: COVID-19, Research Personnel. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Astral Codex 10.
Abstract (Originalsprache)
Human challenge trials (HCTs) may accelerate the development of treatments and vaccines, and deliver novel insights into the course and consequences of infection. However, HCTs are contentious because they involve purposely exposing volunteers to infection. Consultation with the public and other stakeholders is essential for understanding how HCTs can be most ethically and acceptably pursued. Previous research has found public support for COVID-19 HCTs, but little research has considered public attitudes towards HCTs in principle and the various factors making a trial more or less acceptable. Empirical data on the attitudes of research personnel is also missing. We generated an online survey covering overarching support/opposition towards HCTs, as well as factors of importance for deciding whether or not an HCT is ethically acceptable. Our sample of the US public represents the responses of 1500 participants sampled via Prolific , poststratified to be representative of the general US adult population. We additionally collected a convenience sample of 33 research personnel engaged in phase III clinical trials for infectious diseases. Estimates for the US public suggest substantial support for using HCTs to develop new vaccines, new treatments, and knowledge about diseases, with similarly high support among research personnel. The most important factors in determining acceptability of an HCT were the risk to participants and their comprehension of this risk. The general public, in particular, appear relatively unconcerned about participants’ motivations, and favor higher payment in accordance with risk. This study adds to a growing body of public consultation surrounding HCTs, demonstrating high levels of support for their use in principle–not just in relation to COVID-19. The importance attributed to various ethically-relevant factors can help in designing HCTs with high public acceptance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Rethink Priorities, San Francisco, California, United States of America.
- Technion, Israel Institute of Technology, Haifa, Israel.
- Department of Psychology, Georgetown University, Washington, DC, United States of America.
- 1Day Sooner Research Team, Delaware, United States of America.
ORCID-Profile: James William Benjamin Elsey, David Manheim, Abigail Marsh, David Moss
Förderung
- Astral Codex 10
Zitieren
APA
Elsey, J. W. B., Manheim, D., Marsh, A., Schmit, V., & Moss, D. (2024). Ethical acceptability of human challenge trials: Consultation with the US public and with research personnel. PLOS ONE. https://doi.org/10.1371/journal.pone.0307808
Vancouver
Elsey JWB, Manheim D, Marsh A, Schmit V, Moss D. Ethical acceptability of human challenge trials: Consultation with the US public and with research personnel. PLOS ONE. 2024. doi:10.1371/journal.pone.0307808
BibTeX
@article{Elsey2024,
author = {Elsey, James William Benjamin and Manheim, David and Marsh, Abigail and Schmit, Virginia and Moss, David},
title = {Ethical acceptability of human challenge trials: Consultation with the US public and with research personnel},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0307808}
}
EUVIMED